In this paper. we summarise the physiology of lactation and discuss the pathophysiology brought about by fasting. stress and anaesthetic drugs. Drug secretion into breast milk and subsequent absorption by the infant is considered. Maternal hydration must be well maintained with intravenous fluids. allowing an added 500 to 1000 ml for daily fluid loss in lactation. Maternal premedication. general anaesthesia and routine postoperative analgesics are also discussed as to the effects on the breast-fed infant. Drug side-effects may be avoided by timing breast feeding just before the next due dose. Sedatives with long half-lives should not be used. Endocrine and metabolic responses to anaesthesia and surgery are less with regional anaesthesia than with general. hence regional anaesthesia is preferred where it is a reasonable alternative technique.
A lactating woman may produce between 500 to lOOO ml or more of milk each 24 hours. The interval between breast feeds varies from mother to mother although, prior to weaning, it is rarely longer than six hours during the day. Prolongation of the period between breast feeds for anaesthesia and surgery may cause a mother severe discomfort if milk is not expressed.
Pathophysiology of lactation
Normal maintenance of lactation may be disrupted in a number of ways which include: (a) cessation of breast-feeding due to malaise before and after surgery; (b) inadequate maternal hydration due to perioperative nausea and vomiting or preoperative fasting; (c) the effect of drugs given to the mother on the mother; (d) the effect of drugs given to the mother on the infant; (e) the effect of drugs on the normal process of lactation; and (f) the effect of stress of surgery on the mother.
Advantages of breast-feeding
Mothers who are breast-feeding should be encouraged to continue to do so both before and after being given an anaesthetic, unless there is a definite medical contraindication. Breast milk has nutritional, immunological and anti-microbial Anaesthesia and Intensive Care, Vo!. 20, No. 4, November, 1992 properties and breast-feeding itself has emotional benefits to both mother and infant. However, it appears that many mothers are concerned about the effects of anaesthetic drugs on their infants. These mothers may be reassured that, in the past, many women who were breast-feeding have had anaesthetics with no apparent effect on their infants. Anaesthetists should use all available information to give each mother the safest possible anaesthetic, taking into account the need to choose agents which are transmitted to the infant via breast milk only in quantities which are unlikely to result in deleterious effects.
Milk formation
Most of the information on the cellular physiology of lactation comes from studies on the cow and goat. The assumption is made that the process of milk formation and excretion in human mothers is qualitatively similar to that described in animal experiments. 9
Human milk is a suspension of fat in a proteinmineral-carbohydrate solution. There are several types of protein in this milk suspension and they are theoretically able to bind drugs and hence act at transport proteins. Lipid-soluble drugs may also be incorporated into the milk fat globule during fat formation, allowing the drug to be transported in the milk. Water-soluble drugs can be carried in the water component of breast milk.
Drug excretion into breast milk
Drugs are excreted into breast milk by several mechanisms including reverse pinocytosis, carriermediated transport and passive diffusion. The bulk of the data on drug excretion during lactation suggests that passive diffusion is the mode of transfer for most drugs. 1 The concentration of the drug in the mother's plasma is therefore the main determinant of the dose of drug delivered to the breast-fed infant.
There are several factors which will affect drug concentration in milk.
(a) Drug pharmacokinetics
Drugs with high lipid solubility will appear in higher concentration in milk than in plasma (e.g. diazepam).1,2,4,7 On the other hand, low molecular weight ( < 200) water-soluble drugs pass freely into breast milk and will have the same concentration in milk as in plasma (e.g. ephedrine).3,4 Due to the difference in pH of plasma (7.4) and milk (6.5) weak acids will be secreted in lower concentrations in milk than plasma (e.g. thiopentone) while weak bases will undergo 'ion-trapping' in the milk leading to higher concentrations in milk than plasma (e.g. local anaesthetics).1,4,9
High degrees of protein-binding tend to give low concentrations of drug in milk because only the free fraction of the drug is available for transfer (e.g. warfarin).2,4 High degrees of ionization will lead to minimal levels of drug in milk (e.g. muscle relaxants; heparin).9 (b) Timing of drug dose
It has been postulated that between feeds, milk is either stored in mammary ducts, or that it may be supplied on a continuous basis at the time of suckling from the glandular epithelium. The consensus of opinion at present supports the latter theory. 1,9 Continuously produced milk would have a drug concentration reflecting the maternal plasma drug levels at the time of lactation. This concept is very important, as the dose presented to the infant may be minimised by timing breastfeeding just prior to the anaesthesia and as long as possible after the anaesthetic ends.
(c) Maternal hydration
Preoperative fluid restriction or other volume losses may inhibit breast milk formation and hence decrease the volume of milk available to the baby. If the mother has to fast for a prolonged period preoperatively, then it is important that intravenous fluids be prescribed for her. This intravenous fluid requirement should include her daily requirements plus 500 to 1000 ml to allow for fluid loss for lactation, as well as any pathological losses.
(d) Stress
Stress results in a potent negative feedback mechanism to lactation and may inhibit milk formation. Appropriate counselling, reassurance and anxiolytic premedication may play an important role in minimising stress in the anxious patient.
(e) Other possible factors
The breast is a very active metabolic organ. It is possible for breast tissue to metabolise drugs to some degree. This is an area which has not been well researched, as ethical concerns prevent free experimentation on lactating breast tissue in humans. For most anaesthetic and non-anaesthetic drugs which have been studied, the maximum amount secreted in breast milk is seldom greater than 1-2% of the maternal dose. 9
Plasma concentration in infants
The presence of a drug in breast milk does not necessarily lead to significant absorption by the infant. Absorption of a drug from the infant's gastrointestinal tract depends on many factors. Polar drugs are poorly absorbed (e.g. gentamicin) while non-polar ones are more easily absorbed (e.g. penicillin). Once a drug has been absorbed, it travels through the foetal liver to the systemic circulation. The infant has an immature liver, decreased albumen levels and a decreased ability to excrete agents in the urine and stools. The pharmacological effects of drugs on the breast-fed infant may be modified by these physiological differences.
EFFECfS OF GENERAL ANAESTHESIA

Premedication
Sedatives with long half-lives (e.g. diazepam) should be avoided in breast-feeding mothers. Diazepam may cause lethargy and feeding difficulties in the infant. ID Hyperbilirubinemia and floppy infant syndrome have also been reported. 4 These observations were made on babies where the maternal dose was as little as 10 mg. Short-acting sedatives (e.g. midazolam) are found in insignificant amounts in the breast milk and are relatively safe to use for premedication. lo Other sedatives with intermediate elimination half-lives (e.g. chloral hydrate) have been used, but there have been occasional reports of neonatal sleepiness. lo Anti-sialogogues (atropine and hyoscine) have an elimination half-life of between 2-4 hours. Both drugs have been shown to inhibit milk production in mammals. It has not been established to what degree this affects humans. 4 Infants are reportedly sensitive to the anticholinergic effects of atropine and so all tertiary anticholinergics should be used with caution. No information is available on the use of glycopyrrolate.
Opioids are commonly used in premedication. Morphine and pethidine are secreted in mimimal amounts into breast milk following a single dose. 4 Repeated doses, especially of morphine, may have accumulative effects on the infant. 10 Fentanyl secretion into breast milk has not been reported but logic dictates that even though it has a high lipid solubility, its short half-life would lead to minimal amounts being secreted into breast milk. It also has poor oral bioavailability, suggesting there would be little absorption by the infant. Methadone appears to be safe in breast-feeding mothers who are on methadone programs. 1,7 Overseas, diamorphine use has led to reports of dependence and withdrawal effects in infants.7 Papaveretum is probably secreted as is morphine. In view of potential mutagenicity shown in vitro with noscopine (a component of papaveretum), potential risks should be balanced against anticipated benefits when treating the mothers of breast-fed children. 14 ,18
Induction agents
The concentration of thiopentone in breast milk following a normal intravenous induction dose of 4-5 mg/kg is negligible. II ,12 However, if repeated doses are used, or if it is given as an infusion, accumulation may occur and neonatal effects have been reported. 6 ,10 There are no published data on the effects of propofol, either as a bolus or as an infusion on the breast-fed infant. This is in spite of its widespread use in day surgery and for short procedures, which breast-feeding mothers commonly require (e.g. minor gynaecological surgery or incision and drainage of breast abscesses).
Newborns whose mothers receive ketamine for delivery are thought to cry more and are more irritable when exposed to loud noises. 13
Inhalational agents
V olatile anaesthetic agents are found in high concentratioI!s in breast milk, proportional to their fat solubility. 4 The effect ofthese anaesthetic agents on the infant are minimised, as all are eliminated from the mother's circulation in a time course of minutes after the anaesthetic ends. 13 Even highly fat-soluble volatile agents like halothane have minimal effect on infants as the amount absorbed from breast milk is minimal. 4 Nitrous oxide is also safe to use as it, too, is rapidly eliminated from the mother's circulation. 4 However, isoflurane is probably the preferred inhalational agent because of its minimal metabolism and rapid clearance.
Muscle relaxants and reversal
Depolarising and nondepolarising muscle relaxants are minimally excreted into breast milk and cannot be absorbed by the gastrointestinal tract of the infant. 4 These drugs are safe to use. Reversal of muscle relaxation, however, has the potential to cause problems. The effect of atropine on infants has been discussed previously. Neostigmine also has potential undesirable side-effects in the infant but there is no data on concentrations in breast milk, nor on neonatal gastrointestinal absorption. On theoretical grounds, it may be wise to avoid this reversal combination. 4 On the other hand, inadequate reversal of neuromuscular blockade is an important cause of postoperative morbidity. A good argument could be made for the use of vecuronium or atracurium, as these drugs may not require reversal.
Minor analgesics
Minimal amounts of aspirin are secreted into breast milk, and as long as doses of less than 2 grams per day are used there should be no sideeffects on the infant. When larger doses have been used, a tendency to bleed and metabolic acidosis have been reported in the infant. 4 Paracetamol, in doses of 1-2 g per day, has had no reported sideeffects. It has been suggested that paracetamol be avoided when breast-feeding premature infants due to their immature hepatic metabolism. ID While indomethacin is used following caesarean section and laparoscopy for its analgesic and antiinflammatory properties, its use in breast-feeding Anaesthesia and Intensil'e Care, Vu!. 20, No. 4. November. 1992 mothers has been restricted following a case report of neonatal convulsions associated with maternal administration. A recent studyl6 into serum levels of indomethacin in seven breast-fed infants whose mothers were taking therapeutic doses of this drug showed that the infants' exposure to indomethacin is minimal. The average serum levels were 4.2-8.5% of those seen when indomethacin (IV) was used to treat patent ductus arteriosus, and no drug-related side-effects were seen.
Anti-emetics
Metoclopramide is found in high concentrations in breast milk and it is recommended that this drug be avoided in the neonatal period. Information on droperidol is scarce, but with a long half-life it probably also is not a suitable anti-emetic in the breast-feeing mother. However, prochlorperazine appears in smaller quantities in breast milk and should be safer to use during lactation. lO 
REGIONAL ANAESTHESIA
No adverse effects have been reported on breastfed infants following therapeutic doses of local anaesthetic in the mother. The use of ephedrine in therapeutic amounts for the treatment of hypotension during regional anaesthesia is regarded as safe. However, large doses of ephedrine (greater than 30 mg) have been reported to result in irritability and disturbed sleep patterns in one breast-fed infant. 1
Regional anaesthesia should be administered whenever possible in preference to general anaesthesia as it reduces the endocrine and metabolic responses to anaesthesia and surgery,13 and in most cases enables mothers to return to normal dietary intake sooner than following general anaesthesia. Regional anaesthesia also enables mothers to care for their infants without residual drowsiness in the postoperative period.
DISCUSSION
It is difficult to gather data on the effect that a maternal anaesthetic has on a baby who is breastfeeding. Designing a clinical study to provide the required information would be difficult.
For studies to be of value, it would be necessary to administer a variety of anaesthetic drugs to a large number of breast-feeding mothers, and to take samples of their plasma and breast milk and also samples of the infants' plasma and/or urine. This would raise the question of whether it is ethical to expose an infant to the risk of toxic effects from anaesthetic drugs in order to obtain a limited benefit. 1
However, from the data that is available, it is clear that there are several rules of thumb to follow. Preoperatively the patient should be well hydrated and not under undue stress. The infant should be breast-fed before any premedication is given. If premedication is desired, either a short-acting benzodiazepine (oral temazepam or midazolam) or intramuscular opioid (pethidine) should be used.
Intraoperatively, the choice of induction agent or muscle relaxant is oflimited importance. Reversal of neuromuscular blockade with neostigmine and atropine should be used with caution. The use of vecuronium or atracurium may be recommended as they are rapidly cleared from the circulation and require little or no reversal. The choice of inhalational agent has little relevance; however, isoflurane is the least metabolised of the available agents and recovery of consciousness is quick. Short-acting intraoperative opioids are safe provided high doses are not used.
For short procedures there is no apparent contraindication to allowing the patient to breathe spontaneously. Theoretically, balanced anaesthesia with the administration of a muscle relaxant for controlled ventilation allows the anaesthetist to administer a lower concentration of anaesthetic agents.
Postoperatively, if analgesia is required, the commonly used mid-duration opioids are safe. Aspirin and paracetamol also are safe to use if the dosage is less than 2 g per day. Indomethacin can be used in therapeutic doses. The anti-emetic of choice in the neonatal period is probably prochlorperazine.
Following a minor operation, the mother may breast-feed within a few hours of her operation with no adverse effect on her baby. Before elective major surgery the mother may choose to express breast milk, which may be saved and used to feed her baby postoperatively, until she has recovered from the effects of her anaesthetic and surgery. After major surgery it is customary to recommend that the mother should express her breast milk when consciousness returns postoperatively and that this first postoperative quantity of milk should be discarded. The baby may be given a commercial milk preparation until breast-feeding can be resumed.
If a mother is sedated postoperatively due to opioid administration, then it would be advisable for a second person to observe the nursing mother during breast-feeding, so as to prevent injury to the infant if the mother falls asleep. The infant should also be observed for signs of narcosis.
Where possible, regional anaesthesia should be contemplated, as this is least disturbing to a normal breast-feeding schedule. CONCLUSION In this paper, we have coupled a review of a relatively small number of case reports and articles, together with some basic pharmacokinetic principles, to present some guidelines for our colleagues when they are asked to anaesthetise a breast-feeding mother.
